Aging-related systemic manifestations in COPD patients and cigarette smokers

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Boyer, Laurent ^a,b   Chouaïd, Christos ^b,c   Bastuji Garin, Sylvie ^a,b   Marcos, Elisabeth ^c   Margarit, Laurent ^a   Le Corvoisier, Philippe ^a   Vervoitte, Laetitia ^a   Hamidou, Leila ^a   Frih, Lamia ^a   Audureau, Etienne ^a,b   Covali Noroc, Ala ^a   Andujar, Pascal ^c   Saakashvili, Zakaria ^c   Lino, Anne ^a   Ghaleh, Bijan ^a   Hue, Sophie ^a   Derumeaux, Geneviève ^a,b   Housset, Bruno ^c   Dubois Randé, Jean Luc ^a   Boczkowski, Jorge ^b   Maitre, Bernard ^b,c   Adnot, Serge ^a,b   more..

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYTOKINE;

ADULT; AGING; APPENDICULAR SKELETAL MUSCLE MASS INDEX; ARTICLE; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RESISTANCE; LUNG DIFFUSION CAPACITY; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; PULSE WAVE; SMOKING; SPIROMETRY; TELOMERE SHORTENING; ADVERSE EFFECTS; AGED; BLOOD; CASE CONTROL STUDY; GENETICS; LUNG ALVEOLUS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; TELOMERE;

AGED; AGING; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; TELOMERE;

EID: 84925425818     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121539     Document Type: Article

References (30)

1. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009; 33: 1165-1185. doi: 10.1183/09031936.00128008 PMID: 19407051
2. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003; 107: 1514-1519. PMID: 12654609
3. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits L, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health study. Chest. 2009; 136: 1456-1465. doi: 10.1378/chest.08-3016 PMID: 19581353
4. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier J, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 166: 809-813. PMID: 12231489
5. Chandra D, Stamm JA, Palevsky PM, Leader JK, Fuhrman CR, Zhang Y, et al. The relationship between pulmonary emphysema and kidney function in smokers. Chest. 2002; 142: 655-662.
6. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175: 1259-1265. PMID: 17363772
7. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 187: 728-735. doi: 10.1164/rccm.201209-1665OC PMID: 23392440
8. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186: 982-988. doi: 10.1164/rccm.201206-1113OC PMID: 22983959
9. Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CC, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med. 2011; 183: 885-890. doi: 10.1164/rccm.201004-0666OC PMID: 20935108
10. McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 176: 1208-1214. PMID: 17885263
11. Morla M, Busquets X, Pons J, Sauleda J, MacNee W, Agusti AG. Telomere shortening in smokers with and without COPD. Eur Respir J. 2006; 27: 525-528. PMID: 16507852
12. Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 179: 566-571. doi: 10.1164/rccm.200809-1398OC PMID: 19179485
13. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med. 2006; 174: 886-893. PMID: 16888288
14. Noureddine H, Gary-Bobo G, Alifano M, Marcos E, Saker M, Vienney N, et al. Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ res. 2011; 109: 543-553. doi: 10.1161/CIRCRESAHA.111.241299 PMID: 21719760
15. Amsellem V, Gary-Bobo G, Marcos E, Maitre B, Chaar V, Validire P, et al. Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011; 184: 1358-1366. doi: 10.1164/rccm.201105-0802OC PMID: 21885626
16. Dagouassat M, Gagliolo JM, Chrusciel S, Bourin MC, Duprez C, Caramelle P, et al. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2013; 187: 703-714. doi: 10.1164/rccm.201208-1361OC PMID: 23328527
17. Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 189: 30-38.
18. Kirby M, Owrangi A, Svenningsen S, Wheatley A, Coxson HO, Paterson NA, et al. On the role of abnormal DLCO in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. Thorax. 2013; 68: 752-759. doi: 10.1136/thoraxjnl-2012-203108 PMID: 23604381
19. Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, et al. Telomere length as an indicator of biological aging: The gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001; 37: 381-385. PMID: 11230304
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. The European respiratory journal. 1993; 16: 5-40. PMID: 8499054
21. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. American journal of epidemiology. 1998; 147: 755-763. PMID: 9554417
22. Koenker R HK. Quantile regression. Journal of Economic Perspectives, 2001; 15: 143-156.
23. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366: 662-664. PMID: 16112303
24. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med. 2011; 184: 224-232. doi: 10.1164/rccm.201012-2061OC PMID: 21471087
25. Mohamed Hoesein FA, Zanen P, van Ginneken B, van Klaveren RJ, Lammers JW. Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers. Eur Respir J. 2011; 38: 1012-1018. doi: 10.1183/09031936.00050711 PMID: 21565924
26. Cauberghs M, Clement J, Van de Woestijne KP. Functional alterations accompanying a rapid decline in ventilatory function. The American review of respiratory disease. 1993; 147: 379-384. PMID: 8430962
27. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005; 120: 513-522. PMID: 15734683
28. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011; 477: 90-94. doi: 10.1038/nature10357 PMID: 21886162
29. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764. PMID: 15716955
30. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008; 133: 1019-1031. doi: 10.1016/j.cell.2008.03.039 PMID: 18555778